A study of the antigenicity and immunogenicity of a new hepatitis B vaccine using a panel of monoclonal antibodies

Journal of Medical Virology

Volumn 54, Issue 1, 1998, Pages 1-6

  Waters, J A ^a   Bailey, C ^b   Love, C ^c   Thomas, H C ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b Medeva Group Development   (United Kingdom)

^c Evans Medical Ltd   (United Kingdom)

Author keywords

Antigenic structure; Common 'a' determinant; Hepatitis B surface antigen

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; MONOCLONAL ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ANTIBODY DETECTION; ANTIBODY LABELING; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HUMAN; IMMUNOGENICITY; MALE;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; EPITOPE MAPPING; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; MALE; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC;

DNA VIRUSES; HEPATITIS B VIRUS; MAMMALIA;

EID: 0031974613     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199801)54:1<1::AID-JMV1>3.0.CO;2-B     Document Type: Article

References (25)

1. Brown SE, Howard CR, Zuckerman AJ, Steward MW (1984): Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet ii:184-187.
2. Burrell CJ, Leadbetter M, Mackay P, Marmion BP (1976): Intact disulphide bonds are required for full expression of serological activity when the "a" determinant binding site is cleaved from the rest of the HBsAg protein. Journal of General Virology 33:41-50.
3. Ferrari C, Penna A, Bertoletti A, Cavalli A, Valli A, Schianchi C, Fiaccadori F (1989): The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. Journal of Clinical Investigation 84:1314-1319.
4. Gerety RJ (1988): Recombinant hepatitis B vaccines. In Zuckerman AJ (ed): "Viral Hepatitis and Liver Disease." New York: Alan R Liss, pp 1017-1024.
5. Goodall AH, Meek FL, Waters JA, Miescher GC, Janossy G, Thomas HC (1982): A rapid one-step radiometric assay for hepatitis B surface antigen utilising monoclonal antibodies. Journal of Immunological Methods 52:167-174.
6. Howard CR, Brown SE, Hogben DN, Zuckerman AJ, Murray-Lyon IM, Steward MW (1984): Analysis of antibody responses to hepatitis B surface antigen. In Vyas GN, Dienstag JL, Hoofnagle JH (eds): "Viral Hepatitis and Liver Disease." New York: Grune and Stratton, pp 561-572.
7. Howard CR, Stirk HJ, Brown SE, Steward MW (1988): Towards the development of synthetic hepatitis B vaccines. In Zuckerman AJ (ed): "Viral Hepatitis and Liver Disease." New York: Alan R Liss, pp 1094-1101.
8. Imai M, Gotoh A, Nishioka K, Kurashima S, Miyakawa Y, Mayumi M (1974): Antigenicity of reduced and alkylated Australia antigen. Journal of Immunology 112:416-419.
9. Iwarson S, Tabor E, Thomas HC, Goodall A, Waters J, Snoy P, Shih JW-K, Gerety RJ (1985): Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee. Journal of Medical Virology 16:89-96.
10. Jilg W, Lorbeer B, Schmidt H, Wilske B, Zoulek G, Deinhardt F (1984): Clinical evaluation of a recombinant hepatitis B vaccine. Lancet i:1174-1175.
11. Jin Y, Shih WK, Berkower I (1988): Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and non-endosomal processing pathways are accessible to both endogenous and exogenous antigen. Journal of Experimental Medicine 168: 293-306.
12. Koziol DE, Alter HJ, Kirchner JP, Holland PV (1976): The development of HBsAg positive hepatitis despite the previous existence of antibody to HBsAg. Journal of Immunology 117:2260-2262.
13. Le Bouvier GH, Capper RH, Williams AE, Pelletier M, Katz AJ (1976): Concurrently circulating hepatitis B surface antigen and heterotypic anti-HBs antibody. Journal of Immunology 117:2262-2264.
14. McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR (1984): Human hepatitis B vaccine from recombinant yeast. Nature 307:178-180.
15. Milich DR (1988): T- and B-cell recognition of hepatitis B viral antigens. Immunology Today 9:380-386.
16. Mishiro S, Imai M, Takahashi K, Machido A, Gotando T, Miyakawa Y, Mayumi M (1980): A 49,000 dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22nm hepatitis B surface antigen particles. Journal of Immunology 124:1589-1593.
17. Pavlakis GN, Hamer DH (1983): Regulation of a metallothienin-growth hormone hybrid gene in bovine papilloma virus. Proceedings of the National Academy of Sciences 80:387-401.
18. Samonta H, Youn BW (1989): Expression of hepatitis B virus surface antigen containing the pre-S region in mammalian cell culture system. Vaccine 7:69-76.
19. Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A (1980): Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New England Journal of Medicine 303:833-841.
20. Valenzuela P, Medina A, Rutter WJ, Hammerer G, Hall BD (1982): Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298:347-350.
21. Waters J, Pignatelli M, Galpin S, Ishihara K, Thomas HC (1987a): Virus-neutralising antibodies to hepatitis B virus: The nature of an immunogenic epitope on the S gene peptide. Journal of General Virology 67:2467-2473.
22. Waters JA, O'Rourke SM, Richardson SC, Papaevangelou G, Thomas HC (1987b): Qualitative analysis of the humoral immune response to the "a" determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine. Journal of Medical Virology 21:155-160.
23. Waters JA, Brown SE, Steward MW, Howard CR, Thomas HC (1991): Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response. Virus Research 22:1-12.
24. Yoneyama T, Akatsuka T, Miyamura T (1988): Stable expression of the hepatitis B virus surface antigen containing pre-S2 protein in mouse cells using a bovine papillomavirus vector. Journal of General Virology 69:1931-1939.
25. Zuckerman JN, Sabin C, Craig FM, Williams A, Zuckerman AJ (1997): Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: Randomised double blind dose-response study. British Medical Journal 314:329-333.